Alumis Inc. (ALMS)
NASDAQ: ALMS · Real-Time Price · USD
24.41
-1.14 (-4.46%)
At close: Aug 13, 2026, 4:00 PM EDT
24.35
-0.06 (-0.25%)
After-hours: Aug 13, 2026, 7:57 PM EDT
Alumis Employees
As of March 31, 2026, Alumis had 227 total employees, including 225 full-time and 2 part-time employees. The number of employees increased by 3 or 1.34% since the number was last reported on December 31, 2025.
Employees
227
Change
3
Growth
1.34%
Revenue / Employee
$37,013
Profits / Employee
-$1,045,881
Market Cap
3.11B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2026 | 227 | 3 | 1.34% | 225 | 2 |
| Dec 31, 2025 | 224 | 54 | 31.76% | 221 | 3 |
| Dec 31, 2024 | 170 | 61 | 55.96% | 168 | 2 |
| Dec 31, 2023 | 109 | - | - | 107 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,784 |
| Iovance Biotherapeutics | 975 |
| AbCellera Biologics | 562 |
| Tarsus Pharmaceuticals | 370 |
| Arcutis Biotherapeutics | 354 |
| uniQure | 221 |
| Immunome | 206 |
| Celldex Therapeutics | 198 |
ALMS News
- 10 hours ago - Alumis Reports Second Quarter 2026 Financial Results and Highlights Recent Achievements - GlobeNewsWire
- 10 hours ago - Alumis Earnings release: Q2 2026 - Filings
- 10 hours ago - Alumis Quarterly report: Q2 2026 - Filings
- 3 days ago - Alumis announces topline results from ONWARD3 long-term extension study - TheFly
- 6 weeks ago - Alumis management to meet with Cantor - TheFly
- 2 months ago - Alumis rises 10.3% - TheFly
- 3 months ago - Alumis price target raised to $40 from $38 at Chardan - TheFly
- 3 months ago - Alumis Proxy statement: Proxy filing - Filings